Russian Direct investment fund partners with Dr. Reddy's for Sputnik V trials in India|Oneindia News

Video Credit: Oneindia
Published on September 16, 2020 - Duration: 01:03s

Russian Direct investment fund partners with Dr. Reddy's for Sputnik V trials in India|Oneindia News

Dr Reddy's and the Russian Direct Investment Fund (RDIF) have agreed to conduct clinical trials and distribute 100 million doses of Russia's Sputnik V Covid-19 vaccine in India.

The RDIF is Russia's sovereign wealth fund.

Upon regulatory approval in India, the RDIF shall supply to Dr Reddy’s 100 million doses of the vaccine.

The Sputnik V vaccine, which is based on human adenoviral vector platform, is undergoing clinical trials.

Deliveries could potentially begin in late 2020, subject to completion of successful trials and registration of the vaccine by regulatory authorities in India.

The RDIF said its partners will receive an effective and safe drug to fight the novel coronavirus.


You are here

Related news from verified sources

Russia’s sovereign wealth fund – Russian Direct Investment Fund (RDIF) — has partnered Hyderabad-based drug maker Dr Reddy’s Laboratories to cooperate on...
on September 16, 2020 • IndiaTimes

The clinical trials of Sputnik V vaccine for coronavirus will be held this month in several countries including India, confirmed Kirill Dmitriev, CEO of the...
on September 7, 2020 • IndiaTimes

Russia is in close dialogue with the Indian government and the leading drug manufactures of India regarding the localization of production of Sputnik V vaccine...
on September 4, 2020 • IndiaTimes

Related videos from verified sources

Covid-19 cases dip, PM Modi calls for ‘speedy delivery’ of vaccines 05:47
Video credit: HT Digital Content - Published 3 days ago 

Covid-19: India declines proposal to test Sputnik-V Covid-19 vaccine in a large study |Oneindia News 01:16
Video credit: Oneindia - Published 2 weeks ago 

Covid update: N95 mask export allowed; India ranks 4th; festival guidelines 03:14
Video credit: HT Digital Content - Published 2 weeks ago 

You might like